Indo Borax Q1 FY27 consolidated PAT rises to Rs 16.25 Cr on Rs 70.36 Cr revenue
For Q1 FY27, Indo Borax & Chemicals reported consolidated revenue of Rs 70.36 Cr and PAT of Rs 16.25 Cr, up from Rs 53.57 Cr and Rs 10.20 Cr in Q1 FY26.
Key takeaways
- Revenue in Q1 FY27 was Rs 70.36 Cr, up from Rs 53.57 Cr in Q1 FY26.
- EBITDA in Q1 FY27 rose to Rs 19.80 Cr from Rs 12.21 Cr in Q1 FY26.
- PAT in Q1 FY27 increased to Rs 16.25 Cr versus Rs 10.20 Cr in Q1 FY26.
- Company stated EPS for Q1 FY27 stood at Rs 5.07.
- Board approved acquisition of 64.26% equity shares of Kronox Lab Sciences.
Q1 FY27 · consolidated
| Metric | Jun 2026 | Jun 2025 | Change |
|---|---|---|---|
| Revenue | Rs 70.36 Cr | Rs 53.57 Cr | +31.3% |
| PAT | Rs 16.25 Cr | Rs 10.20 Cr | +59.3% |
As reported in the filing. Figures are transcribed, not computed.
• Revenue (Q1 FY27, consolidated): Rs 70.36 Cr, up from Rs 53.57 Cr in Q1 FY26, as shown in the revenue chart in the investor presentation.
• EBITDA (Q1 FY27, consolidated): Rs 19.80 Cr, compared with Rs 12.21 Cr in Q1 FY26, according to the EBITDA chart in the investor presentation.
• PAT (Q1 FY27, consolidated): Rs 16.25 Cr, versus Rs 10.20 Cr in Q1 FY26, as per the PAT chart in the investor presentation.
According to the Q1 FY27 consolidated performance charts in the investor presentation, Indo Borax & Chemicals reported an increase in operating revenue to Rs 70.36 Cr in Q1 FY27 from Rs 53.57 Cr in Q1 FY26. The company also highlighted in the performance notes that consolidated operating revenue grew by 31.34% year-on-year to Rs 70.36 Cr.
The same charts in the investor presentation show EBITDA rising to Rs 19.80 Cr in Q1 FY27 from Rs 12.21 Cr in Q1 FY26. In the accompanying performance highlights, the company stated that EBITDA increased by 62.16% year-on-year to Rs 19.80 Cr, and mentioned an EBITDA margin of 28.14% for the quarter.
Profit after tax also increased on a consolidated basis. The PAT chart in the investor presentation shows PAT of Rs 16.25 Cr in Q1 FY27, compared with Rs 10.20 Cr in Q1 FY26. In the performance commentary below the charts, the company noted that net profit rose by 59.31% year-on-year to Rs 16.25 Cr and that earnings per share for the quarter stood at Rs 5.07.
In its management commentary section of the investor presentation, the company attributed the Q1 FY27 performance to higher capacity utilization, better realizations, strategic expansion initiatives and steady domestic demand. The company also referred to continued focus on fiscal discipline, operational excellence and value creation. The post-quarter developments section of the presentation records that the board of directors approved a scheme of amalgamation of its wholly owned subsidiary, Indoborax Infrastructure Private Limited, with Indo Borax & Chemicals Ltd., and approved the acquisition of 64.26% equity shares of Kronox Lab Sciences, along with an open offer proposal, describing these as steps aimed at creating greater efficiency, larger reach and more effective utilization of combined resources.
Track Indo Borax & Chemicals Ltd-$
Cruxal reads every Indo Borax & Chemicals Ltd-$ filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Get every filing that moves a stock
One email before the open, with the day's filings that actually shifted a price — the number, the source document and what the market did with it. Free, and you can unsubscribe from any issue.
Cruxal publishes market coverage for information only. Nothing here is investment advice.
